Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 657

1.

How medical choices influence quality of life of women carrying a BRCA mutation.

Harmsen MG, Hermens RP, Prins JB, Hoogerbrugge N, de Hullu JA.

Crit Rev Oncol Hematol. 2015 Jul 26. pii: S1040-8428(15)30010-X. doi: 10.1016/j.critrevonc.2015.07.010. [Epub ahead of print] Review.

PMID:
26299336
2.

Longitudinal evaluation of the natural history of conservatively managed non-functioning pituitary adenomas.

Lenders N, Ikeuchi S, Russell AW, Ho KK, Prins JB, Inder WJ.

Clin Endocrinol (Oxf). 2015 Aug 20. doi: 10.1111/cen.12879. [Epub ahead of print]

PMID:
26291181
3.

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.

Harmsen MG, Arts-de Jong M, Hoogerbrugge N, Maas AH, Prins JB, Bulten J, Teerenstra S, Adang EM, Piek JM, van Doorn HC, van Beurden M, Mourits MJ, Zweemer RP, Gaarenstroom KN, Slangen BF, Vos MC, van Lonkhuijzen LR, Massuger LF, Hermens RP, de Hullu JA.

BMC Cancer. 2015 Aug 19;15(1):593. doi: 10.1186/s12885-015-1597-y.

5.

Unstable Foxp3+ Regulatory T Cells and Altered Dendritic Cells Are Associated with Lipopolysaccharide-Induced Fetal Loss in Pregnant IL10-Deficient Mice.

Prins JR, Zhang B, Schjenken JE, Guerin LR, Barry SC, Robertson SA.

Biol Reprod. 2015 Jul 29. pii: biolreprod.115.128694. [Epub ahead of print]

6.

Quantification of naive and memory T-cell turnover during HIV-1 infection.

Vrisekoop N, Drylewicz J, Van Gent R, Mugwagwa T, Van Lelyveld S, Veel E, Otto SA, Ackermans MT, Vermeulen JN, Huidekoper HH, Prins JM, Miedema F, de Boer RJ, Tesselaar K, Borghans JA.

AIDS. 2015 Jul 24. [Epub ahead of print]

PMID:
26213901
7.

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

van Lelyveld SF, Drylewicz J, Krikke M, Veel EM, Otto SA, Richter C, Soetekouw R, Prins JM, Brinkman K, Mulder JW, Kroon F, Middel A, Symons J, Wensing AM, Nijhuis M, Borghans JA, Tesselaar K, Hoepelman AI; MIRS study group.

PLoS One. 2015 Jul 24;10(7):e0132430. doi: 10.1371/journal.pone.0132430. eCollection 2015.

8.

BREATH: Web-Based Self-Management for Psychological Adjustment After Primary Breast Cancer-Results of a Multicenter Randomized Controlled Trial.

van den Berg SW, Gielissen MF, Custers JA, van der Graaf WT, Ottevanger PB, Prins JB.

J Clin Oncol. 2015 Sep 1;33(25):2763-71. doi: 10.1200/JCO.2013.54.9386. Epub 2015 Jul 13.

PMID:
26169621
9.

Brief Report: Anal Cancer in the HIV-Positive Population: Slowly Declining Incidence After a Decade of cART.

Richel O, Van Der Zee RP, Smit C, De Vries HJ, Prins JM.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):602-5. doi: 10.1097/QAI.0000000000000675.

PMID:
26167621
10.

HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care.

Joore IK, Arts DL, Kruijer MJ, Moll van Charante EP, Geerlings SE, Prins JM, van Bergen JE.

Sex Transm Infect. 2015 Jun 30. pii: sextrans-2015-052073. doi: 10.1136/sextrans-2015-052073. [Epub ahead of print]

PMID:
26126531
11.

Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.

Mekuria LA, Prins JM, Yalew AW, Sprangers MA, Nieuwkerk PT.

PLoS One. 2015 Jun 26;10(6):e0130649. doi: 10.1371/journal.pone.0130649. eCollection 2015.

12.

Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial.

Visser A, van Laarhoven HW, Woldringh GH, Hoogerbrugge N, Prins JB.

Acta Oncol. 2015 Jun 26:1-10. [Epub ahead of print]

PMID:
26114234
13.

Fear of cancer recurrence in colorectal cancer survivors.

Custers JA, Gielissen MF, Janssen SH, de Wilt JH, Prins JB.

Support Care Cancer. 2015 Jun 25. [Epub ahead of print]

PMID:
26108170
14.

Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease.

Iyer A, Brown L, Whitehead JP, Prins JB, Fairlie DP.

FASEB J. 2015 Jun 11. pii: fj.15-271155. [Epub ahead of print] Review.

PMID:
26065858
15.
16.

Negative predictors for satisfaction in patients seeking facial cosmetic surgery: a systematic review.

Herruer JM, Prins JB, van Heerbeek N, Verhage-Damen GW, Ingels KJ.

Plast Reconstr Surg. 2015 Jun;135(6):1596-605. doi: 10.1097/PRS.0000000000001264. Review.

PMID:
26017596
17.

EnD-Seq and AppEnD: sequencing 3' ends to identify nontemplated tails and degradation intermediates.

Welch JD, Slevin MK, Tatomer DC, Duronio RJ, Prins JF, Marzluff WF.

RNA. 2015 Jul;21(7):1375-89. doi: 10.1261/rna.048785.114. Epub 2015 May 26.

PMID:
26015596
18.

Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence.

van de Wal MA, Gielissen MF, Servaes P, Knoop H, Speckens AE, Prins JB.

BMC Psychol. 2015 Apr 16;3(1):12. doi: 10.1186/s40359-015-0068-1. eCollection 2015.

19.

Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus.

Holland DJ, Marwick TH, Haluska BA, Leano R, Hordern MD, Hare JL, Fang ZY, Prins JB, Stanton T.

Heart. 2015 Jul;101(13):1061-6. doi: 10.1136/heartjnl-2014-307391. Epub 2015 May 2.

PMID:
25935767
20.

Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics.

Kokil GR, Veedu RN, Ramm GA, Prins JB, Parekh HS.

Chem Rev. 2015 Jun 10;115(11):4719-43. doi: 10.1021/cr5002832. Epub 2015 Apr 28. No abstract available.

PMID:
25918949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk